MolecuLight’s device boosts healing by 204% in diabetic foot ulcer trial
Participant quality of life showed a deviation toward improvement at four weeks in the MolecuLight arm.

Participant quality of life showed a deviation toward improvement at four weeks in the MolecuLight arm.
The system can replace fingerstick blood glucose measurements to provide information for diabetes treatment decisions.
The automated, quantitative fingerstick assay can deliver results in less than seven minutes from sample application.
The device was shown to boost survival and insulin secretion of cells in preclinical models.
V-Go is worn like a patch on the body and offers continuous insulin infusion to manage blood sugar levels.
The solution will incorporate Abbott’s FreeStyle Libre 3 sensor, CamDiab's CamAPS FX algorithm and Ypsomed’s mylife YpsoPump.
The Eversense E3 CGM system is designed to accurately track patients' glucose levels.
The non-invasive saliva test will be developed for patients with diabetes as an alternative to finger-prick glucose testing.
Thank you for subscribing to Medical Device Network